Global Health Information & Medical Research Institute
.
Research
Please select one of the substances below that GHI/MRI has researched.

Description
Regarding Liquid Deprenyl-
Liquid Deprenyl Citrate (LDC) was developed by Discovery Experimental & Development Inc. (DEDI). This product was available to the public for 9 years from 1991 to 2000. Unlike any similiar product that was (or is) available on the market, LDC was proven effective regarding quality of life in the ederly, to include but not limited to cognitive & moter function, synile dementia, hormone release, inihibiting toxic free raticals, sex drive disfunction, revival of dying brain cells, Parkinsons Disease, Alzhimers Disease, ALS, High Blood Presure, Stroke induced paralysis, Depression, and learning ability.
Just prior to the United States government shutting down Discovery Experimental, huge breakthrews had been discovered concerning LDC by the Hahnemann Clinic. The Hahnemann Clinic found that cancer could be treated much more effectivly using DEDI's LDC as an adjunct with other cancer treatments. The Hahnemann Clinic had discovered that DEDI's LDC normalized the Epenifren, Noripenefren, and Seratonin levels within the body. It was found that cancer patients' Epenifren, Noripenifren, and Seratonin levels were grossly abnormal and while they were abnormal the cancer was very difficult to treat. However, when these levels were normalized by the use of Liquid Deprenyl Citrate the Cancer was easily addressed.
Learn More About Liquid Deprenyl Citrate